Evidence map›Paper›PMID 39982916›Full record

ArticlePLoS biology2025

RIPK1 is required for ZBP1-driven necroptosis in human cells.

Oluwamuyiwa T Amusan, Shuqi Wang, Chaoran Yin, Heather S Koehler, Yixun Li, Tencho Tenev, Rebecca Wilson, Benjamin Bellenie, Ting Zhang, Jian Wang and 9 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  3. Review
  4. Article
  5. Cell death network regulation in HSV infection: immune evasion versus host defense.Apoptosis : an international journal on programmed cell death · 2026
    Review
  6. Article
  7. Regulated cell death programs shaping cancer therapy.Cellular oncology (Dordrecht, Netherlands) · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Mixed Lineage Kinase Domain-Like Protein (MLKL): From Mechanisms to Therapeutic Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Oluwamuyiwa T AmusanDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Shuqi WangDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Chaoran YinBlood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Heather S KoehlerSchool of Molecular Biosciences, Washington State University, Pullman, Washington State, United States of America.
Yixun LiDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Tencho TenevThe Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
Rebecca WilsonThe Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
Benjamin BellenieCentre for Cancer Drug Discovery at the Institute of Cancer Research, London, United Kingdom.
Ting ZhangBlood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Jian WangDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Chang LiuDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Kim SeongDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Seyedeh L PoorbaghiDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Joseph YatesDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Yuchen ShenDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Jason W UptonDepartment of Biological Sciences, Auburn University, Auburn, Alabama, United States of America.
Pascal MeierThe Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
Siddharth BalachandranBlood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Hongyan GuoDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.ORCID 0000-0002-6286-1741

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell DeathR01AI135025 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI BALACHANDRAN, SIDDHARTH · 2017 to 2025
$6.8M
Targeting RIPK3 in Flu-Associated Lung InjuryR01AI144400 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI BALACHANDRAN, SIDDHARTH, CUNY, GREGORY D · 2019 to 2023
$3.6M
Role of ZBP1 in pathogenesis of Salmonella biofilmsR01AI171568 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI SIDDHARTH BALACHANDRAN, Cagla Tukel · 2023 to 2026
$3.4M
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapyR01CA269975 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI SIDDHARTH BALACHANDRAN, VASILY M STUDITSKY · 2023 to 2026
$3.0M
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsivenessR56AI168087 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI BALACHANDRAN, SIDDHARTH, LANGLOIS, RYAN · 2023 to 2023
$834k
Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) EncephalitisR21AI175590 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GUO, HONGYAN · 2023 to 2024
$402k
NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA269975NIAID NIH HHS R01 AI135025NIAID NIH HHS R01 AI144400NIAID NIH HHS R01 AI171568NIAID NIH HHS R21 AI175590NIAID NIH HHS R56 AI168087NIGMS NIH HHS P20 GM134974
6 · The paper itself

Abstract

Necroptosis initiated by the host sensor Z-NA binding protein 1 (ZBP1) is essential for host defense against a growing number of viruses, including herpes simplex virus 1 (HSV-1). Studies with HSV-1 and other necroptogenic stimuli in murine settings have suggested that ZBP1 triggers necroptosis by directly complexing with the kinase RIPK3. Whether this is also the case in human cells, or whether additional co-factors are needed for ZBP1-mediated necroptosis, is unclear. Here, we show that ZBP1-induced necroptosis in human cells requires RIPK1. We have found that RIPK1 is essential for forming a stable and functional ZBP1-RIPK3 complex in human cells, but is dispensable for the formation of the equivalent murine complex. The receptor-interacting protein (RIP) homology interaction motif (RHIM) in RIPK3 is responsible for this difference between the 2 species, because replacing the RHIM in human RIPK3 with the RHIM from murine RIPK3 is sufficient to overcome the requirement for RIPK1 in human cells. These observations describe a critical mechanistic difference between mice and humans in how ZBP1 engages in necroptosis, with important implications for treating human diseases.

Indexed as

NecroptosisReceptor-Interacting Protein Serine-Threonine KinasesRNA-Binding ProteinsAnimalsHEK293 CellsHerpesvirus 1, HumanHumansMiceReceptor-Interacting Protein Serine-Threonine KinasesRIPK1 protein, humanRipk1 protein, mouseRIPK3 protein, humanRipk3 protein, mouseRNA-Binding ProteinsZBP1 protein, humanZbp1 protein, mouse

Identifiers

PMID39982916
PMCPMC11844899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.